AHRQ on gauging macular degeneration
This article was originally published in The Gray Sheet
Executive Summary
Agency for Healthcare Research & Quality posts final 1technology assessment on the scientific validity of patient-reported outcomes for age-related macular degeneration, identifying vision-specific questionnaires such as NEI-VFQ and VF-14 as the most appropriate quality-of-life instruments that still correspond "moderately" with traditional visual performance measures. CMS' Medicare Coverage Advisory Committee has considered such issues when weighing available evidence supporting AMD treatments (2"The Gray Sheet" Nov. 28, 2005, p. 7)...